￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Whether Vemurafenib has been officially included in the scope of medical insurance reimbursement

2026-02-01 22:25:32

Check Details
How to alleviate the side effects of resmetirom

2026-02-01 22:25:32

Check Details
What is Revumenib-Revuforj? Indications and functions

2026-02-01 22:25:32

Check Details
What class of drugs does Selegiline/imidopyr belong to?

2026-02-01 22:25:32

Check Details
Does the new drug Etrasimod-Velsipity belong to the category of biologics?

2026-02-01 22:25:32

Check Details
What are the main functions and efficacy of vemurafenib/zobovo?

2026-02-01 22:25:32

Check Details
Can resmetirom be used to treat cirrhosis?

2026-02-01 22:25:32

Check Details
What is the usage and dosage of Revumenib-Revuforj?

2026-02-01 22:25:32

Check Details
How many times a day should you take selegiline/midopir?

2026-02-01 22:25:32

Check Details
How many pills of Etrasimod-Velsipity should be taken per day?

2026-02-01 22:25:32

Check Details
Do you need to continue taking Vemurafenib/Zorbovo tablets after taking them?

2026-02-01 22:25:32

Check Details
Durvalumab/Infinifer versus atezolizumab

2026-02-01 22:25:32

Check Details
Category
相关知识